A trial with 108 participants suggests the vaccine is safe and may be moderately effective. But experts noted that the approach has failed in the past.
Published: May 22, 2020 at 09:58PM
from NYT Health https://ift.tt/3cWzsdo
A trial with 108 participants suggests the vaccine is safe and may be moderately effective. But experts noted that the approach has failed in the past.
Published: May 22, 2020 at 09:58PM
from NYT Health https://ift.tt/3cWzsdo